Walleye Capital LLC Relay Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 927,137 shares of RLAY stock, worth $3.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
927,137
Previous 1,819,983
49.06%
Holding current value
$3.16 Million
Previous $12.9 Million
70.36%
% of portfolio
0.01%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding RLAY
# of Institutions
207Shares Held
159MCall Options Held
100KPut Options Held
26.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$95.2 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$51.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$36 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$30.5 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$27.5 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $410M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...